1492 Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

1492 Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,115	Closed	-$3.52M	–	128
2022 Q2	$3.52M	Sell	49,115 -733	-1%	-$53.6K	2.32%	10
2022 Q1	$4.04M	Buy	49,848 +27,423	+122%	+$2.32M	2.14%	10
2021 Q4	$2.3M	Buy	22,425 +42	+0.2%	+$4.03K	1.13%	30
2021 Q3	$1.96M	Sell	22,383 -388	-2%	-$35.1K	0.99%	38
2021 Q2	$2.04M	Hold	22,771	–	–	1.04%	37
2021 Q1	$1.73M	Sell	22,771 -650	-3%	-$49K	0.98%	40
2020 Q4	$1.6M	Buy	23,421 +1,837	+9%	+$115K	0.92%	35
2020 Q3	$1.15M	Buy	21,584 +1,260	+6%	+$75K	0.86%	38
2020 Q2	$1.18M	Sell	20,324 -99	-0.5%	-$5.32K	1.01%	32
2020 Q1	$805K	Sell	20,423 -19	-0.1%	-$1.11K	0.96%	36
2019 Q4	$1.22M	Sell	20,442 -76	-0.4%	-$4.08K	1.08%	29
2019 Q3	$1.09M	Sell	20,518 -733	-3%	-$37.6K	1.06%	30
2019 Q2	$1.09M	Sell	21,251 -328	-2%	-$15.3K	1.02%	32
2019 Q1	$1.12M	Sell	21,579 -2,141	-9%	-$104K	0.95%	35
2018 Q4	$933K	Buy	23,720 +8,404	+55%	+$390K	0.84%	38
2018 Q3	$790K	Buy	+15,316	New	+$750K	0.51%	62

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1492 Capital Management's SYNH Position: Q3 2022 in Review

1492 Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 49,115 shares — an estimated $3.52M sold.

1492 Capital Management first reported a position in SYNH in Q3 2018 and held it in 16 quarters. The position peaked at $4.04M in Q1 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

1492 Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
1492 Capital Management sold 49,115 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $3.52M.
1492 Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 16 quarters.
1492 Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $4.04M in Q1 2022.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on 1492 Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.